Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Interleukin-12 (IL-12) is a potent immunotherapeutic agent.

Saved in:

Bibliographic Details
Main Authors:	Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S. Chard, Nicholas R. Lemoine, Yaohe Wang
Format:	article
Language:	EN
Published:	Nature Portfolio 2017
Subjects:	Science Q
Online Access:	https://doaj.org/article/84f37118338744888cbe6343b27f3c3f
Tags:	Add Tag No Tags, Be the first to tag this record!

id	oai:doaj.org-article:84f37118338744888cbe6343b27f3c3f
record_format	dspace
spelling	oai:doaj.org-article:84f37118338744888cbe6343b27f3c3f2021-12-02T14:40:21ZRe-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent10.1038/s41467-017-01385-82041-1723https://doaj.org/article/84f37118338744888cbe6343b27f3c3f2017-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-01385-8https://doaj.org/toc/2041-1723Interleukin-12 (IL-12) is a potent immunotherapeutic agent.Pengju WangXiaozhu LiJiwei WangDongling GaoYuenan LiHaoze LiYongchao ChuZhongxian ZhangHongtao LiuGuozhong JiangZhenguo ChengShengdian WangJianzeng DongBaisui FengLouisa S. ChardNicholas R. LemoineYaohe WangNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-15 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Pengju Wang Xiaozhu Li Jiwei Wang Dongling Gao Yuenan Li Haoze Li Yongchao Chu Zhongxian Zhang Hongtao Liu Guozhong Jiang Zhenguo Cheng Shengdian Wang Jianzeng Dong Baisui Feng Louisa S. Chard Nicholas R. Lemoine Yaohe Wang Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
description	Interleukin-12 (IL-12) is a potent immunotherapeutic agent.
format	article
author	Pengju Wang Xiaozhu Li Jiwei Wang Dongling Gao Yuenan Li Haoze Li Yongchao Chu Zhongxian Zhang Hongtao Liu Guozhong Jiang Zhenguo Cheng Shengdian Wang Jianzeng Dong Baisui Feng Louisa S. Chard Nicholas R. Lemoine Yaohe Wang
author_facet	Pengju Wang Xiaozhu Li Jiwei Wang Dongling Gao Yuenan Li Haoze Li Yongchao Chu Zhongxian Zhang Hongtao Liu Guozhong Jiang Zhenguo Cheng Shengdian Wang Jianzeng Dong Baisui Feng Louisa S. Chard Nicholas R. Lemoine Yaohe Wang
author_sort	Pengju Wang
title	Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_short	Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_full	Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_fullStr	Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_full_unstemmed	Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
title_sort	re-designing interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/84f37118338744888cbe6343b27f3c3f
work_keys_str_mv	AT pengjuwang redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT xiaozhuli redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT jiweiwang redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT donglinggao redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT yuenanli redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT haozeli redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT yongchaochu redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT zhongxianzhang redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT hongtaoliu redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT guozhongjiang redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT zhenguocheng redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT shengdianwang redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT jianzengdong redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT baisuifeng redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT louisaschard redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT nicholasrlemoine redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent AT yaohewang redesigninginterleukin12toenhanceitssafetyandpotentialasanantitumorimmunotherapeuticagent
_version_	1718390307219832832

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Similar Items